Calamos Advisors »

Vaxcyte shares owned by Calamos Advisors

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $694k 10k 68.31

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Vaxcyte

FMR
Vanguard Group
BlackRock
RA Capital Management
Henderson Group
Wellington Management Company
Capital Research Global Investors
T. Rowe Price Investment Management
State Street Corporation
T. Rowe Price Associates
Darwin Global Management
Geode Capital Management
Franklin Resources
Perceptive Advisors
Driehaus Capital Management

View all funds holding Vaxcyte